TORONTO,, Dec. 1, 2004 (PRIMEZONE) -- * Food Safe's technology, ozone equipment and distribution in Europe and Asia to be launched through Apollo Scientific. Food Safe's ozone equipment and distribution to be incorporated into Apollo Scientific and marketed for multiple applications.
Food Safe International, Inc. (Pink Sheets:FSIJ) announced today that new officers and directors of the company have been appointed as part of the acquisition of Apollo Scientific Group, a Biotech Research & Development company. Over the next few weeks Food Safe intends to announce its new corporate office locations, name change, trading symbol change and a new website.
The new CEO, Eugene Zabolotsky, most recently served as President of the EZMED Inc., a consulting company that provides business services to healthcare corporations, ranging from medical group practices to start-up biotechnology companies seeking to introduce products or services to the marketplace, his skills in technology commercialization and raising capital will be invaluable to the growth of Food Safe International.
Mr. Zabolotsky stated, "We are very pleased with recent developments and looking forward to taking FSIJ to the next level, we look forward to putting together a new management team and advisory board to bring value to this company and enhance shareholder value."
About Food Safe International
Food Safe intends to eliminate food safety and sanitation issues and provide methods to improve procedures to minimize risk and liability. Food is one of the most mobile commodities traded internationally. Consumers are asking more questions and demanding answers. Whether the commodity is spices (insect contamination), beef (E. coli), strawberries (Hepatitis A, salmonella), fish (mercury) or any of thousands of foods traded globally, consumers and buyers are demanding new standards of quality, safety and nutritional value. Protecting people from food borne illness is Food Safe's number-one priority. Food Safe's comprehensive program is a proactive approach to food safety. Spurred into action by food crises in the global beef industry, there is an international consensus that producers and food industry stakeholders require a reliable methodology and technology for verifying food production and food safety.
About Apollo Scientific Group
Apollo's biotech R&D division intends to develop and market pharmaceuticals in the therapeutic areas of oncology, cardiology, diabetes and other life threatening diseases. Additionally, Apollo has been researching and is developing the business model for creating stem cell banks and stem cell treatment facilities. Apollo Scientific Group has a seasoned management team, supportive advisors and investor base.
Safe Harbor Statement:
This information includes certain "forward-looking statements." The forward-looking statements reflect the beliefs, expectations, objectives, and goals of the Company management with respect to future events and financial performance. They are based on assumptions and estimates, which are believed reasonable at the time such statements are made. However, actual results could differ materially from anticipated results. Important factors that may impact actual results include, but are not limited to commodity prices, political developments, legal decisions, market and economic conditions, industry competition, the weather, changes in financial markets and changing legislation and regulations. Matters discussed in this press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company. Forward-looking statements are intended to qualify for the safe harbor provisions of Section 21E of the Securities and Exchange Act of 1934, as amended.